Position in ORMP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,705
+$47,701 QoQ
Shares Held
9,918
+495800.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 84 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ORMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. ORMP ranks #271 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in ORMP
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,705 | 9,918 | Shares | Defined | 2026-08-13 | |
| 2023-12-31 | $4 | 2 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33 | 13 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $1,563 | 130 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $835 | 129 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $313,043 | 68,350 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $649,104 | 75,041 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $289,398 | 20,266 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $118,516 | 5,392 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $13,768 | 1,029 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||